Lisata Therapeutics Stock Price Patterns
| LSTA Stock | USD 4.55 0.01 0.22% |
Momentum 87
Buy Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.62) | EPS Estimate Current Year (2.33) | EPS Estimate Next Year (1.02) | Wall Street Target Price 11.3333 | EPS Estimate Current Quarter (0.54) |
Using Lisata Therapeutics hype-based prediction, you can estimate the value of Lisata Therapeutics from the perspective of Lisata Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lisata Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Lisata because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lisata Therapeutics after-hype prediction price | USD 4.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Lisata Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lisata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lisata Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Lisata Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lisata Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lisata Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lisata Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Lisata Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lisata Therapeutics' historical news coverage. Lisata Therapeutics' after-hype downside and upside margins for the prediction period are 0.23 and 16.22, respectively. We have considered Lisata Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lisata Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Lisata Therapeutics is based on 3 months time horizon.
Lisata Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Lisata Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lisata Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lisata Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.88 | 11.61 | 0.06 | 0.07 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.55 | 4.61 | 1.32 |
|
Lisata Therapeutics Hype Timeline
Lisata Therapeutics is now traded for 4.55. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of 0.07. Lisata is anticipated to increase in value after the next headline, with the price projected to jump to 4.61 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.32%, whereas the daily expected return is now at 1.88%. The volatility of related hype on Lisata Therapeutics is about 30552.63%, with the expected price after the next announcement by competition of 4.62. The company reported the previous year's revenue of 1000 K. Net Loss for the year was (19.98 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Lisata Therapeutics Basic Forecasting Models to cross-verify your projections.Lisata Therapeutics Related Hype Analysis
Having access to credible news sources related to Lisata Therapeutics' direct competition is more important than ever and may enhance your ability to predict Lisata Therapeutics' future price movements. Getting to know how Lisata Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lisata Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MTVA | MetaVia | (0.29) | 8 per month | 0.00 | (0.18) | 11.60 | (20.10) | 79.95 | |
| NCNA | NuCana PLC | 0.11 | 6 per month | 0.00 | (0.19) | 6.53 | (7.92) | 20.76 | |
| ENLV | Enlivex Therapeutics | 0.05 | 6 per month | 4.42 | 0.04 | 8.57 | (8.16) | 24.21 | |
| PASG | Passage Bio | 0.21 | 3 per month | 6.82 | 0.02 | 10.28 | (9.87) | 58.13 | |
| XCUR | Exicure | (0.05) | 8 per month | 8.47 | 0.05 | 21.22 | (11.88) | 63.80 | |
| CASI | CASI Pharmaceuticals | 0.1 | 10 per month | 0.00 | (0.15) | 11.84 | (7.69) | 35.41 | |
| CLSD | Clearside Biomedical | 0.36 | 6 per month | 0.00 | (0.27) | 7.96 | (17.54) | 83.67 | |
| PTHS | Pelthos Therapeutics | 0.07 | 20 per month | 0.00 | (0.17) | 7.75 | (9.03) | 24.67 | |
| KLTO | Klotho Neurosciences | 0.01 | 2 per month | 0.00 | (0.18) | 9.09 | (10.00) | 27.00 | |
| CLGN | Collplant Biotechnologies | (0.19) | 5 per month | 0.00 | (0.13) | 8.61 | (12.50) | 77.60 |
Lisata Therapeutics Additional Predictive Modules
Most predictive techniques to examine Lisata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lisata using various technical indicators. When you analyze Lisata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lisata Therapeutics Predictive Indicators
The successful prediction of Lisata Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lisata Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lisata Therapeutics based on analysis of Lisata Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lisata Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lisata Therapeutics's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.73 | 0.76 | Price To Sales Ratio | 28.54 | 27.12 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Lisata Stock analysis
When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |